Related Experiment Video
Updated: Jul 27, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Release of soluble ICAM-5, a neuronal adhesion molecule, in acute encephalitis
Perttu J Lindsberg1, J Launes, L Tian
1Department of Neurology, Helsinki University Central Hospital, FIN-00029 HUS, Helsinki, Finland. perttu.lindsberg@hus.fi
Insights
Soluble intercellular adhesion molecule-5 (sICAM-5) is elevated in cerebrospinal fluid during acute encephalitis, correlating with cognitive function and leukocyte counts. This suggests sICAM-5 plays a role in neuroinflammation and immune responses.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Intercellular adhesion molecule-5 (ICAM-5), also known as telencephalin, is expressed in telencephalic neurons and mediates neuron-leukocyte binding.
- Human cerebral neurons express ICAM-5, facilitating neuron-leukocyte interactions in the central nervous system (CNS).
Purpose of the Study:
- To investigate the expression and role of ICAM-5 during clinical CNS inflammation.
- To determine if soluble ICAM-5 (sICAM-5) levels in cerebrospinal fluid (CSF) are altered in patients with neurological inflammatory conditions.
Main Methods:
- Immunoblotting was used to identify a soluble form of ICAM-5 (sICAM-5).
- An ELISA assay was developed to quantify sICAM-5 levels.
- CSF samples from patients with acute encephalitis, multiple sclerosis (MS), and healthy controls were analyzed.
Main Results:
- sICAM-5 levels were significantly increased in patients with acute encephalitis compared to those with MS and healthy controls (p < 0.001).
- CSF sICAM-5 concentration correlated with immediate recall performance (p = 0.013) and CSF leukocyte count (p = 0.02).
- A strong correlation was observed between sICAM-5 and leukocyte count in herpes simplex virus (HSV) encephalitis cases (r = 0.94; p = 0.002).
Conclusions:
- sICAM-5 is released into the CSF during acute encephalitis, indicating its involvement in CNS inflammation.
- sICAM-5 may mediate leukocyte-neuron interactions and actively regulate immune responses during microbial neuroinvasion.
- The findings suggest sICAM-5 is a potential biomarker for encephalitis and a mediator of immune cell adhesion in the brain.
Background:
Intercellular adhesion molecule (ICAM)-5 (telencephalin) is an adhesion molecule in telencephalic neurons of the mammalian brain that binds to the leukocyte integrin CD11a/CD18. The authors observed that human cerebral neurons also expressed ICAM-5 and that ICAM-5--mediated neuron--leukocyte binding in cultured hippocampal neurons. This led the authors to examine ICAM-5 expression during clinical CNS inflammation.
Methods:
The authors found, by immunoblotting, a 115-kDa soluble form of ICAM-5 (sICAM-5) cleaved from the membrane-bound (130 kDa) ICAM-5, and established an ELISA assay to measure it. CSF samples of patients with acute encephalitis and MS were studied.
Results:
sICAM-5 was increased in encephalitis (320 plus minus 107 ng/mL; n = 25), as compared with patients with MS (128 plus minus 10 ng/mL; n = 16) and control subjects without CNS disease (137 plus minus 6 ng/mL; n = 42) (p < 0.001). The concentration of sICAM-5 correlated with the performance in the immediate recall task (p = 0.013) and with the leukocyte count in the CSF (p = 0.02), especially in cases caused by herpes simplex virus (HSV) (r = 0.94; p = 0.002).
Conclusions:
sICAM-5 is cleaved from CNS into CSF during acute encephalitis, and it may mediate leukocyte--neuron interactions. sICAM-5 release from cerebral neurons may actively regulate immune responses and leukocyte adhesion during microbial neuroinvasion in humans during encephalitis.
More Related Videos
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Viral Meningitis
Arboviral Encephalitis
Acute Inflammation II: Cellular Phase
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

